top of page
Home
Our Science
Astatine-211 Targeted Alpha Therapies
FLEX-NK Bifunctional Antibodies
Our Team
News & Resources
Media
Contact Us
Management Team
Chief Executive Officer
Daniel Teper,
PharmD, MBA
Executive Vice President
Michael G. King
Chief Communications Officer
Lyn Falconio
Chief Operating Officer
Raquel Cabo
Chief Business Officer
Ravi Kiron,
PhD
Chief Medical Officer
Dan Chiche,
MD
Head of Product Development
Vidisha Mohad,
PhD
Board of Directors
Laurent Audoly,
PhD
Daniel D'Agostino,
MBA
Ely Benaim,
MD
Melissa Fensterstock,
MPhil, MBA
Chris Nowers
BsC Hons
Daniel Teper,
PharmD, MBA
Alexandra Urman,
MPH
bottom of page